PAREXEL Enhances ClinPhone RTSM Service
PAREXEL announced enhancements to its Randomization and Trial Supply Management (RTSM) service.
PAREXEL announced the following enhancements to its Randomization and Trial Supply Management (RTSM) service, ClinPhone® RTSM:
· Speed and efficiency: typically ready for use in four to eight weeks
· Configuration and customization: tailored to meet the demands of different phases of clinical development, local regulators, regional requirements, and client or protocol specific needs
· Adaptability: rapid turnaround and minimal timeline disruption for study changes before or during the trial\
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
